Structural basis for RKIP binding with its substrate Raf1 kinase

Biotechnol Lett. 2014 Sep;36(9):1869-74. doi: 10.1007/s10529-014-1558-6. Epub 2014 May 27.

Abstract

Raf1 kinase inhibitor protein (RKIP) negatively regulates the Raf1/MEK/ERK pathway which is vital for cell growth and differentiation. It is also a biomarker in clinical cancer diagnosis. RKIP binds to the N-terminus of Raf1 kinase but little is known about the structural basis of RKIP binding with Raf1. Here, we demonstrate that the N-terminus of human Raf1 kinase (hRaf11-147aa) binds with human RKIP (hRKIP) at its ligand-binding pocket, loop "127-149", and the C-terminal helix by NMR experiments. D70, D72, E83, Y120, and Y181 were further verified as the key residues participating in the interaction of hRKIP and hRaf11-147aa. G143-R146 fragment was also critical for hRKIP binding with hRaf11-147aa, for its deletion decreased the binding affinity around 300 times, from 154 to 0.46 mM(-1). Our results provide important structural clues for designing the lead compound that disrupts RKIP-Raf1 interaction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Humans
  • Magnetic Resonance Spectroscopy
  • Phosphatidylethanolamine Binding Protein / chemistry*
  • Phosphatidylethanolamine Binding Protein / metabolism*
  • Protein Binding
  • Protein Interaction Mapping*
  • Proto-Oncogene Proteins c-raf / chemistry*
  • Proto-Oncogene Proteins c-raf / metabolism*
  • Sequence Deletion

Substances

  • PEBP1 protein, human
  • Phosphatidylethanolamine Binding Protein
  • Proto-Oncogene Proteins c-raf